H. Obara et al., Overexpression of truncated I kappa B alpha induces TNF-alpha-dependent apoptosis in human vascular smooth muscle cells, ART THROM V, 20(10), 2000, pp. 2198-2204
Dysregulation of apoptosis is one of the likely underlying mechanisms of ne
ointimal thickening, a disorder in which proinflammatory cytokines may infl
uence the function of vascular smooth muscle cells (VSMCs) and contribute t
o atherogenesis. One of these cytokines, tumor necrosis factor-alpha (TNF-a
lpha), induces 2 possibly conflicting pathways, 1 leading to the activation
of nuclear factor-kappaB (NF-kappaB) and the other leading to caspase-medi
ated apoptosis. We investigated whether specific inhibition of NF-kappaB af
fects TNF-alpha -dependent apoptosis in human VSMCs. To inhibit NF-kappaB a
ctivation specifically, we constructed a recombinant adenovirus vector expr
essing a truncated form of the inhibitor protein I kappaB alpha (AdexI kapp
aB DeltaN) that lacks the phosphorylation sites essential for activation of
NF-kappaB. The I kappaB DeltaN was overexpressed by adenoviral infection a
nd was resistant to stimulus-dependent degradation. Electromobility gel shi
ft and luciferase assays demonstrated that overexpression of I kappaB Delta
N inhibited NF-kappaB activation induced by TNF-alpha or interleukin-1 beta
(IL-1 beta). In cells overexpressing I kappaB DeltaN, TNF-alpha dramatical
ly induced apoptosis, whereas IL-1 beta had no effect. The induction was su
ppressed by treatment with a selective inhibitor of the caspase-3 family, Z
-DEVD-fmk, and the overexpression of I kappaB DeltaN induced TNF-alpha -med
iated caspase-3 and caspase-2 activity. These results indicate that overexp
ression of I kappaB DeltaN induces TNF-alpha -dependent apoptosis by effici
ent and specific suppression of NF-kappaB and upregulation of caspase-3 and
caspase-2 activity in human VSMCs. Our findings suggest that adenovirus-me
diated I kappaB DeltaN gene transfer may be useful in the treatment of diso
rders associated with inflammatory conditions, such as the response to vasc
ular injury and atherosclerosis.